Continuing studies of the peripheral vascular actions of dopamine.
D000818:Animals; D001464:Barium / Q000037:antagonists & inhibitors; D001488:Basilar Artery / Q000187:drug effects*; D003250:Constriction; D003331:Coronary Vessels / Q000187:drug effects*; D004106:Dilatation; D004285:Dogs; D004298:Dopamine / Q000494:pharmacology*; D005263:Femoral Artery / Q000187:drug effects*; D006321:Heart / Q000187:drug effects*; D007980:Levodopa / Q000494:pharmacology; D008638:Mesenteric Arteries / Q000187:drug effects*; D010643:Phenoxybenzamine / Q000037:antagonists & inhibitors; D011433:Propranolol / Q000037:antagonists & inhibitors; D011448:Prostaglandin Antagonists; D011955:Receptors, Drug; D012077:Renal Artery / Q000187:drug effects*; D013015:Sotalol / Q000037:antagonists & inhibitors; D013329:Structure-Activity Relationship; D014665:Vasodilator Agents; D014667:Vasopressins / Q000037:antagonists & inhibitors
D011448:Prostaglandin Antagonists; D011955:Receptors, Drug; D014665:Vasodilator Agents; D010643:Phenoxybenzamine; D014667:Vasopressins; D001464:Barium; D007980:Levodopa; D011433:Propranolol; D013015:Sotalol; D004298:Dopamine